AMP-activated protein kinase control of energy metabolism in the ischemic heart

International Journal of Obesity : Journal of the International Association for the Study of Obesity
G D Lopaschuk

Abstract

Myocardial ischemia produces an energy-deficient state in heart muscle, which if not corrected can lead to cardiomyocyte death. AMP-activated protein kinase (AMPK) is a key kinase that can increase energy production in the ischemic heart. During ischemia a rapid activation of AMPK occurs, resulting in an activation of both myocardial glucose uptake and glycolysis, as well as an increase in fatty acid oxidation. This activation of AMPK has the potential to increase energy production, thereby protecting the heart during ischemic stress. However, at clinically relevant high levels of fatty acids, ischemia-induced activation of AMPK also stimulates fatty acid oxidation during and following ischemia. This can contribute to ischemic injury secondary to an inhibition of glucose oxidation, which results in a decrease in cardiac efficiency. As a result, AMPK activation has the potential to be either beneficial or harmful in the ischemic heart.

References

Sep 1, 1978·The American Journal of Cardiology·H S Mueller, S M Ayres
Sep 1, 1991·Journal of Molecular and Cellular Cardiology·S C DennisL H Opie
Oct 8, 1965·Annals of the New York Academy of Sciences·P J RandleC N Hales
Jul 1, 1994·American Heart Journal·G D LopaschukB A Finegan
Jun 1, 1997·European Journal of Biochemistry·D G Hardie, D Carling
Jul 17, 1999·The American Journal of the Medical Sciences·P F KantorG D Lopaschuk
Nov 15, 2001·The Journal of Biological Chemistry·Markus Frederich, James A Balschi
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C PeraltaJ Roselló-Catafau
Jan 28, 2003·Biochemical Society Transactions·T A HopkinsG D Lopaschuk
Aug 2, 2003·The Journal of Biological Chemistry·Suzanne KovacicJason R B Dyck
Apr 8, 2004·American Journal of Physiology. Endocrinology and Metabolism·Kei SakamotoDario R Alessi
Jul 23, 2004·The Journal of Biological Chemistry·Arzu Onay-BesikciGary D Lopaschuk
Oct 28, 2004·The Journal of Biological Chemistry·Judith Y AltarejosGary D Lopaschuk
Nov 24, 2004·Nature Medicine·Rei ShibataKenneth Walsh
Jan 18, 2005·Circulation Research·Suzanne J BaronLawrence H Young
Dec 8, 2005·American Journal of Physiology. Endocrinology and Metabolism·Kei SakamotoLuc Bertrand
Dec 24, 2005·Circulation Research·Christophe DepreStephen F Vatner
Jan 24, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Carrie-Lynn M SoltysJason R B Dyck
Nov 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Min XieMichael D Schneider

❮ Previous
Next ❯

Citations

Mar 17, 2010·Cardiovascular Drugs and Therapy·Marta A PaivaMihaela M Mocanu
Feb 16, 2011·The Journal of Biological Chemistry·Kari T ChambersDaniel P Kelly
Mar 1, 2012·Seminars in Cardiothoracic and Vascular Anesthesia·Anja FrankTobias Eckle
Aug 16, 2012·Heart Failure Reviews·Min Park, Gary Sweeney
Oct 27, 2015·International Journal of Molecular Medicine·Jiajia YanMiaomiao Xi
Jan 10, 2016·Journal of Molecular and Cellular Cardiology·Vlad G ZahaLawrence H Young
Jul 4, 2012·Molecular and Cellular Endocrinology·Jeevan NagendranJason R B Dyck
Aug 6, 2011·Trends in Molecular Medicine·Mohamed Kodiha, Ursula Stochaj
Mar 2, 2010·The Journal of Surgical Research·Linghai LiBingxi Zhang
Jan 19, 2012·European Journal of Heart Failure·Hossein ArdehaliMihai Gheorghiade
May 14, 2011·Journal of Cellular and Molecular Medicine·Arie GruzmanShlomo Sasson
Mar 31, 2016·European Journal of Nutrition·Roseane Maria Maia Santos, Darcy Roberto Andrade Lima
Jan 13, 2011·The American Journal of Pathology·Makhosazane ZunguMonte S Willis
May 26, 2015·European Journal of Pharmacology·Zhouqing HuangWeijian Huang
Jan 16, 2013·The Journal of Thoracic and Cardiovascular Surgery·Krishna K SinghSubodh Verma
Jul 16, 2016·Biochimica Et Biophysica Acta·Suresh C BairwaJason R B Dyck
Nov 26, 2010·Cardiovascular Research·Christian F Rueda-ClausenSandra T Davidge
Feb 6, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Wenguang ChangLi Chen
Apr 12, 2018·Physiology·Harpreet S Bajaj, Bernard Zinman
Jun 11, 2010·Current Opinion in Cardiology·John D HorowitzAaron L Sverdlov
Dec 15, 2015·Physiological Reviews·Monique N Foster, William A Coetzee
Sep 16, 2011·American Journal of Physiology. Cell Physiology·Mohamed KodihaUrsula Stochaj
Apr 28, 2021·Physiology·Simone C da Silva RosaGary Sweeney

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.